Search

You searched for "cleft"

2288 results found

2020 Lancet Commission on dementia: a call to action for integrated hearing healthcare

3 March 2021 | | ENTA - Audiology - Adult, ENTA - Audiology - Diagnostic
Dr Georgiou’s summary of the 2020 update to the 2017 Lancet Commission underscores the importance of medical and hearing healthcare professionals working together to tackle the modifiable risk factors that affect individuals throughout their lives, to help delay or even...

Wisdom and the cochlear implant clinician

5 January 2022 | | ENTA - Audiology - Adult, ENTA - Audiology - Auditory Implants
Helen Cullington provides the clinician’s perspective on the challenges faced in building artificial intelligence into cochlear implant clinics. She highlights the importance of including the clinician with their wisdom and experience to help make sense of the patterns of data....

Rapid genetic testing to avoid hearing loss in neonates

2 September 2022 | | ENTA - Audiology - Diagnostic, ENTA - Audiology - Paediatric, ENTA - Otology
Thousands of newborn babies could avoid a lifetime of hearing loss thanks to a new rapid genetic test. In this article, we learn how. We have demonstrated for the first time that a rapid genetic test from a cheek swab...

Tish Gaffney – AAA President

4 March 2025 | | ENTA - Audiology - Adult
From a sunny Southend, UK, Gareth Smith takes 10 minutes to dial into the Sunshine State, USA, and catch up with Tish Gaffney for a lightning-speed chat on the movements and motivations of the 35th president of the American Academy...

HearAdvisor’s scientific and consumer-friendly approach to evaluating hearing aids

4 September 2023 | | ENTA - Audiology - Adult, ENTA - Audiology - Auditory Implants
An ageing population means more hearing aid users. The authors of this article describe their techniques for independently assessing prescription and over-the-counter hearing aids in an acoustic laboratory. As the role of consumers in the hearing aid purchasing decision continues...

Take-home tinnitus care – Sound Relief App

1 July 2016 | | ENTA - Audiology - Adult, ENTA - Tinnitus
Tinnitus is a condition that affects over 300 million people worldwide. Typically it manifests as a ringing or buzzing in the ears and while there is not yet a cure there are many ways for patients to manage their tinnitus....

In conversation with AAA President, Jackie Clark

1 January 2018 | | ENTA - Audiology - Adult, ENTA - Audiology - Diagnostic, ENTA - Audiology - Paediatric
Jackie Clark, PhD, is a clinical audiologist, professor of audiology, and researcher. She is also the new President of the American Academy of Audiology (AAA). While on an annual working trip to South Africa, Jackie answered a few questions about...

Global hearing rehabilitation – an SFORL/IFOS collaboration

1 September 2018 | | ENTA - Audiology - Adult, ENTA - Audiology - Paediatric
International collaboration is more important than ever, and we hear from Prof Bernard Fraysse about a collaboration that grew out of the very successful IFOS meeting in Paris in 2017. The IFOS meeting in Paris in June 2017 was obviously...

Andreas Wagner: ESPO 2025 keynote speaker

4 March 2025 | | ENTA - Paediatrics
The keynote speaker for ESPO 2025 in Stuttgart is renowned evolutionary biologist and author Professor Andreas Wagner, from Zurich. Prof Wagner will focus on the congress theme of ‘Innovation’, giving us his unique perspective on how evolution drives human creativity....

FDA Approved Lenire Expands Number of US Clinics

1 March 2024 | Company Profiles, Contracts & Distributors, Research & Development
Neuromod Devices, the medical technology company that developed tinnitus treatment device, Lenire, has partnered with an additional 24 new US clinics to address the significant demand for the FDA Approved tinnitus treatment device.

Controlled clinical trial results for FDA-approved tinnitus treatment device Lenire published in Nature Communications

12 September 2024 | Company Profiles, Research & Development
Nature Communications has published the peer-reviewed results of Neuromod Devices’ TENT-A3 (Treatment Evaluation of Neuromodulation for Tinnitus – Stage A3) clinical trial for the first and only FDA-approved bimodal tinnitus treatment device, Lenire.

BACO – the early years

1 March 2015 | | ENTA - ENT
The origins of the British Academic Conference in Otolaryngology (BACO) are indelibly intertwined in the mists of time with the foundation of the British Association of Otolaryngology (BAO). For further information on the latter I can only refer the interested...